Literature DB >> 28666934

Flow Energy Loss Evaluation in a Systolic Anterior Motion Case After the Ross Procedure.

Koichi Akiyama1, Yoshifumi Naito2, Mao Kinoshita2, Maki Ishii2, Yasufumi Nakajima3, Keiichi Itatani4, Takako Miyazaki4, Masaaki Yamagishi4, Hitoshi Yaku4, Teiji Sawa2.   

Abstract

Keywords:  Ross Procedure; flow energy loss; systolic anterior motion; transesophageal echocardiography; vector flow mapping

Mesh：

Year:  2017        PMID： 28666934     DOI： 10.1053/j.jvca.2017.03.006

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  4 in total

1.  Energetic performance index improvement after Glenn and Damus-Kaye-Stansel procedure using vector flow mapping analysis: a case report.

Authors:  Atsushi Kainuma; Koichi Akiyama; Yoshifumi Naito; Kazuma Hayase; Hisayuki Hongu; Keiichi Itatani; Masaaki Yamagishi; Teiji Sawa
Journal:  JA Clin Rep       Date:  2020-01-21

2.  Preoperative Left Ventricular Energy Loss in the Operating Theater Reflects Subjective Symptoms in Chronic Aortic Regurgitation.

Authors:  Atsushi Kainuma; Keiichi Itatani; Koichi Akiyama; Yoshifumi Naito; Maki Ishii; Masaru Shimizu; Junya Ohara; Naotoshi Nakamura; Yasufumi Nakajima; Satoshi Numata; Hitoshi Yaku; Teiji Sawa
Journal:  Front Surg       Date:  2022-02-14

3.  Energetic performance analysis of staged palliative surgery in tricuspid atresia using vector flow mapping.

Authors:  Mao Kinoshita; Koichi Akiyama; Keiichi Itatani; Ayahiro Yamashita; Maki Ishii; Atsushi Kainuma; Yoshinobu Maeda; Takako Miyazaki; Masaaki Yamagishi; Teiji Sawa
Journal:  Cardiovasc Ultrasound       Date:  2017-12-14       Impact factor: 2.062

4.  Image-Based Computational Hemodynamics Analysis of Systolic Obstruction in Hypertrophic Cardiomyopathy.

Authors:  Ivan Fumagalli; Piermario Vitullo; Christian Vergara; Marco Fedele; Antonio F Corno; Sonia Ippolito; Roberto Scrofani; Alfio Quarteroni
Journal:  Front Physiol       Date:  2022-01-06       Impact factor: 4.566
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.